Global Infertility Treatment Industry Press Release
Portland, OR -- (SBWIRE) -- 10/04/2017 -- According to a recent report published by Progressive Markets on the health sector, which titled, "Global Infertility Treatment Market- Size, Trend, Share, Opportunity Analysis & Forecast, 2014-2025", the industry is expected to increase at a CAGR of 11.7% during the period, 2017–2025. It is suitable for manufacturers and stakeholders owing to comprehensive analysis it offers of factors that increase or decrease growth of the market.
The research gives a brief introduction of the global infertility treatment market in terms of its scope. It offers summary which includes significant findings, market attractiveness, competitive landscape, recent developments, and trend analysis. It incorporates research methodology, such as Porter's Five Forces Analysis (PFFA) to understand rivalry in the industry. This also includes bargaining power of the supplier & buyer and threat from substitutes & new entrepreneurs. It divides the industry into procedures, products, patients, end-users, and geographies.
Based on procedure, the study segments the global infertility treatment market into assisted reproductive technology (ART), fertility surgeries, and artificial insemination (AI). According to it, products of the industry include instruments, accessories, and media & consumables. Geographically, it segments the market into Europe, North America, Latin America Middle East & Africa (LAMEA), and Asia-Pacific. It splits the industry on the basis of patients into women and men.
Get PDF Brochure of this Report: https://www.progressivemarkets.com/request-sample/infertility-treatment-market
The report includes end-users of the global infertility treatment market, such as fertility centers, research institutes, hospitals & clinics, and cryobanks. It analyzes share of the industry by types, procedures, patients, end-users, and geographies during the period, 2014–2025. It assesses market size of each product, procedure, patient, and end-user by region for the historic period and forecast period, 2014–2016 and 2017–2025, respectively. In addition, it evaluates market size of all nations of the industry during the aforementioned period.
The experts describe features that cause slow progress of the global infertility treatment market, such as high procedural cost. Moreover, the study provides certain key takeaways of the industry, such as it provides great competitive edge to manufacturers, stakeholders, and new entrants. It provides comprehensive evaluation of aspects that have potential to restrict or drive the industry.
The study discusses big market players of the global infertility treatment market, such as Cooper Companies Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Cook Group Incorporated (U.S.), Vitrolife AB (Sweden), Genea Limited (Australia), Esco Micro Pte. Ltd. (Singapore), IVFtech ApS (Denmark), Irvine Scientific (U.S.), Baker Company, Inc. (U.S.)., and Ihmedical A/S. It offers brief introduction of every manufacturer. Further, it analyzes business and finance segment of each company. It also evaluates recent advancements made by every firm. The experts describe various factors that vendors adopt to evolve market trends. These include product development, acquisition, product approval, and collaboration. The report explores factors that accelerate growth of the industry which include technological development. It discusses alternate aspects that propel demand of the industry, such as increase in awareness and public- private investment.